Loss of Smad3 in acute T-cell lymphoblastic leukemia

New England Journal of Medicine

Volumn 351, Issue 6, 2004, Pages 552-559

  Wolfraim, Lawrence A ^a   Fernandez, Tania M ^a   Mamura, Mizuko ^a   Fuller, Walter L ^a   Kumar, Rajesh ^a   Cole, Diane E ^a   Byfield, Stacey ^a   Felici, Angelina ^a   Flanders, Kathleen C ^a   Walz, Thomas M ^b   Roberts, Anita B ^a   Aplan, Peter D ^a   Balis, Frank M ^a   Letterio, John J ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c NIH Bldg 41 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN P27; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA BINDING PROTEIN; INTERLEUKIN 2; SMAD3 PROTEIN, HUMAN; SMAD3 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ALLELE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; EXON; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; T LYMPHOCYTE; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ANIMAL; BIOSYNTHESIS; DNA SEQUENCE; GENE DELETION; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

ADULT; ANIMALS; CELL CYCLE PROTEINS; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA-BINDING PROTEINS; EXONS; GENE DELETION; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; LEUKEMIA, T-CELL; LEUKEMIA, T-CELL, ACUTE; MICE; MICE, KNOCKOUT; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS;

EID: 3442886238     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa031197     Document Type: Article

References (13)

1. Derynck R, Zhang Y. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003;425:577-84.
2. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29. [Erratum, Nat Genet 2001;29:351.]
3. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29. [Erratum, Nat Genet 2001;29:351.]
4. Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo P, Poplack D, eds. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins, 2002:489-544.
5. Piekarz RL, Robey R, Sandor V, et al. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T cell lymphoma: a case report. Blood 2001;98:2865-8.
6. Flanders KC, Kim ES, Roberts AB. ImmunohistochemicaI expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas. Dev Dyn 2001;220:141-54.
7. Yang X, Letterio JJ, Lechleider RJ, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999;18:1280-91.
8. Komuro H, Valentine MB, Rubnitz JE, et al. p27KIP1 deletions in childhood acute lymphoblastic leukemia. Neoplasia 1999;1:253-61.
9. Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 1996;85:721-32.
10. Chervinsky DS, Zhao XF, Lam DH, Ellsworth M, Gross KW, Aplan PD. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol Cell Biol 1999;19:5025-35.
11. Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997;3:222-5.
12. Kip1 is abrogated by multiple mechanisms in aggressive malignant lymphomas. Br J Haematol 2003;121:739-48.
13. Morosetti R, Kawamata N, Gombart AF, et al. Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 1995;86:1924-30.